The Series A round was led by AlbionVC with participation from HTH and InHealth Ventures.
"Over the last six years, we have been creating and developing our patient-centric sensor-based technology and platform to transform neuro-rehab. In clinical studies, NeuroBall was proven to motivate patients to do hundreds of movement repetitions independently at home, which led to significant improvements in the range of motion, reduction of arm pain and return to daily activities using their arm and hand after a stroke. This has proven transformative to neuro-rehab as previously patients would not have access to in-person physical or occupational therapy due to factors such as insurance, financial, transportation and health barriers. We’re excited to partner with AlbionVC, HTH, and InHealth Ventures, and are hugely grateful for their support to scale our unique neurological therapeutics platform that we believe will change the world of neuro-rehab."
The London technology start-up raised the capital from SuperSeed to expand its brand advocacy platform.
"We’re in the depths of a people-powered revolution when it comes to growing consumer brands, as now content created by real people influences so many of our purchase decisions, not ads generated by businesses."
The Series A round was led by Fuel Ventures alongside a crowdfunding campaign.
"Wombat has come a long way in the last three years and closing this funding round is another key milestone on our journey to help more budding investors embrace the habit of saving and investing for their futures,"
